Highly Predictive Ligand-based Pharmacophore and Homology Models of ABHD6

Chemical Biology and Drug Design

Volumn 81, Issue 3, 2013, Pages 382-388

  Bowman, Anna L ^a   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Drug design; Enzyme structure; Molecular modeling; Virtual screening

Indexed keywords

ALPHA BETA HYDROLASE DOMAIN CONTAINING 6; HYDROLASE; HYDROLASE INHIBITOR; UNCLASSIFIED DRUG; WWL 70;

ARTICLE; DRUG BINDING SITE; DRUG DESIGN; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; LIGAND BINDING; MOLECULAR MODEL; PHARMACOPHORE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BINDING SITES; DATABASES, FACTUAL; DRUG DESIGN; ENZYME INHIBITORS; LIGANDS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; MONOACYLGLYCEROL LIPASES; PROTEIN STRUCTURE, TERTIARY; ROC CURVE; SEQUENCE ALIGNMENT;

EID: 84873746337     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12086     Document Type: Article

References (35)

1. Blankman J.L., Simon G.M., Cravatt B.F. (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol;14:1347-1356.
2. Ghafouri N., Tiger G., Razdan R.K., Mahadevan A., Pertwee R.G., Martin B.R., Fowler C.J. (2004) Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Br J Pharmacol;143:774-784.
3. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L. et al. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA;99:10819-10824.
4. Dinh T.P., Kathuria S., Piomelli D. (2004) RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol;66:1260-1264.
5. Marrs W.R., Blankman J.L., Horne E.A., Thomazeau A., Lin Y.H., Coy J. et al. (2010) The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci;13:951-957.
6. Comelli F., Giagnoni G., Bettoni I., Colleoni M., Costa B. (2007) The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation. Br J Pharmacol;152:787-794.
7. Hohmann A.G. (2007) Inhibitors of monoacylglycerol lipase as novel analgesics. Br J Pharmacol;150:673-675.
8. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R. et al. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature;435:1108-1112.
9. Saario S.M., Laitinen J.T. (2007) Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. Basic Clin Pharmacol Toxicol;101:287-293.
10. Bisogno T., Di Marzo V. (2008) The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses. Curr Pharm Des;14:2299-2305.
11. Max D., Hesse M., Volkmer I., Staege M.S. (2009) High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors. Cancer Sci;100:2383-2389.
12. Li F., Fei X.W., Xu J.X., Ji C.N. (2009) An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines. Mol Biol Rep;36:691-696.
13. Zvonok N., Williams J., Johnston M., Panarinathan L., Janero D.R., Li J. et al. (2008) Full mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purification. J Proteome Res;7:2158-2164.
14. Zvonok N., Williams J., Johnston M., Panarinathan L., Karageorgos I., Janero D.R. et al. (2008) Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted proteomic characterization of the catalytic site. Chem Biol;15:854-862.
15. Labar G., Bauvois C., Borel F., Ferrer J., Wouters J., Lambert D.M. (2010) Crystal structure of the human monoacylglycerol lipase, a key factor in endocannabinoid signaling. ChemBioChem;11:218-227.
16. Bertrand T., Augé F., Houtmann J., Rak A., Vallée F., Mikol V. et al. (2010) Structural basis for human monoglyceride lipase inhibition. J Mol Biol;396:663-673.
17. Karageorgos I., Tyukhtenko S., Zvonok N., Janero D.R., Sallum C., Makriyannis A. (2010) Identification by nuclear magnetic resonance spectroscopy of an active-site hydrogen-bond network in human monoacylglycerol lipase (hMGL): implications for hMGL dynamics, pharmacological inhibition, and catalytic mechanism. Mol BioSyst;6:1381-1388.
18. Vandevoorde S. (2008) Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors. Curr Top Med Chem;8:247-267.
19. Kapanda C.N., Mucci G.G., Labar G., Poupaert J.H., Lambert D.M. (2009) Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors. J Med Chem;52:7310-7314.
20. Long J.Z., Jin X., Adibekian A., Li W.W., Cravatt B.F. (2010) Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases. J Med Chem;53:1830-1842.
21. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E. et al. (2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol;5:37-44.
22. Navia-Paldanius D., Savinainen J.R., Laitinen J.T. (2012) Biochemical and pharmacological characterization of human alpha/beta-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12). J Lipid Res;53:2413-2424.
23. Li W.W., Blankman J.L., Cravatt B.F. (2007) A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J Am Chem Soc;129:9594-9595.
24. Lichtman A.H., Blankman J.L., Cravatt B.F. (2010) Endocannabinoid overload. Mol Pharmacol;78:993-995.
25. Chanda P.K., Gao Y., Mark L., Btesh J., Strassle B.W., Lu P.M. et al. (2010) Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol;78:996-1003.
26. Fiskerstrand T., Brahim D.H.B., Johanssond S., M'Zahem A., Haukanes B.I., Drouot N. et al. (2010) Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet;87:410-417.
27. Bachovchin D.A., Ji T.Y., Li W.W., Simon G.M., Blankman J.L., Adibekian A. et al. (2010) Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening. Proc Natl Acad Sci USA;107:20941-20946.
28. Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T. et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem;47:1739-1749.
29. Halgren T.A., Murphy R.B., Friesner R.A., Beard H.S., Frye L.L., Pollard W.T. et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem;47:1750-1759.
30. Horsman G.P., Ke J., Dai S., Seah S.Y.K., Bolin J.T., Eltis L.D. (2006) Kinetic and structural insight into the mechanism of BphD, a C-C bond hydrolase from the biphenyl degradation pathway. Biochemistry;45:11071-11086.
31. Jones D.T. (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol;292:195-202.
32. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J.H., Zhang Z., Miller W. et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res;25:3389-3402.
33. Jacobson M.P., Pincus D.L., Rapp C.S., Day T.J.F., Honig B., Shaw D.E. et al. (2004) A hierarchical approach to all-atom protein loop prediction. Proteins;55:351-367.
34. Xu M.A., Lill M.A. (2012) Utilizing experimental data for reducing ensemble size in flexible-protein docking. J Chem Inf Model;52:187-198.
35. Sherman W., Beard H.S., Farid R. (2006) Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des;67:83-84.